More articles from Molecular Targeting Probes-Radioactive & Nonradioactive - Preclinical Probes for Oncology

You have access
An enzyme cleavage induced targeted retention (EnCItR) platform enhancing the theranostic potential of radiopharmaceuticals
Siqi Zhang, Jieting Shen, Xin Gao, Jiang Wu, Lulu Zhang, Xingkai Wang, Hailong Zhang, Feng Wang, Rui Wang and Kuan Hu

Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 241847;
You have access
Development of 68Ga-labeled PD-L1 tracers based on multivalent D-peptide
Xiaona Sun, Yuxuan Wu, Jiang Wu, Shuo Jiang, Siqi Zhang, Xingkai Wang, Xin Gao, Lulu Zhang, Feng Wang, Rui Wang and Kuan Hu

Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 241838;
You have access
Development of 68Ga/177Lu-LNC1011 for theranostics of prostate cancer
Hongzhang Yang, Xuejun Wen, Huifeng Guo, Jingjing Zhang, Zijian Zhou and Xiaoyuan Chen

Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 241513;
You have access
Construction and preclinical immnoPET imaging of a gallium-68 radiolabeled specific nanobody for targeting CD147 detection in pan-cancer
Xiaokun Ma, Teli Liu, Hua Zhu and Zhi Yang

Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 241673;
You have access
Preclinical evaluation of novel PSMA-targeted radiotracers for prostate tumor imaging and treatment in mouse models
Xin Gao, Jiang Wu, Yuxuan Wu, Xiaona Sun, Siqi Zhang, Hailong Zhang, Feng Wang, Rui Wang and Kuan Hu

Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 241829;
You have access
Automated Radiosynthesis of 18F-FluoFAPI and Its Single Acute Dose Toxicological Evaluation
Jason Witek, Sahil Kapila, Wade Winton, Jenelle Stauff, Peter Scott, Benjamin Viglianti and Allen Brooks

Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 241777;
You have access
Development of novel bi-modal agents for combination use of Auger electron therapy and photodynamic therapy
Hiroyuki Watanabe, Ryotaro Onoue and Masahiro Ono

Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 241892;
You have access
An integrin-Î±5Î²1 targeting PET tracer with improved imaging performance
Jieting Shen, Siqi Zhang, Jiang Wu, Lulu Zhang, Hailong Zhang, Lin Xie, Rui Wang, Ming-Rong Zhang and Kuan Hu

Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 241834;
You have access
StarPEG nanocarriers: A versatile nanoplatform for tumor imaging and therapy
Niranjan Meher, Gary Ashley, Anju Wadhwa, Kondapa Bobba, Anil Bidkar, Chandrashekhar Dasari, Changhua Mu, Cyril Fong, Ramya Sankaranarayanan, Juan Antonio Camara Serrano, Umama Ali, Veronica Steri, Jun Zhu, Rahul Aggarwal, Renuka Sriram, Jonathon Chou, Daniel Santi, Youngho Seo, Robert Flavell and Henry VanBrocklin

Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 241764;
You have access
Preclinical evaluation of [155Tb]Tb-crown-TATE as an imaging and dosimetry tool for therapy with [225Ac]Ac-crown-TATE
Luke Wharton, Diduo Zhang, Maryam Osooly, Cristina Rodriguez-Rodriguez, Helen Merkens, Peter Kunz, Francois Benard and Hua Yang

Journal of Nuclear Medicine June 1, 2024, 65 (supplement 2) 241571;

Main menu

User menu

Search

More articles from Molecular Targeting Probes-Radioactive & Nonradioactive - Preclinical Probes for Oncology

Pages